Moderna Stock News

Even if it isn't too late, Ocugen might not be a good investment.

Moderna is going head-to-head with Pfizer-BioNTech for the opportunity to vaccinate the youngest children, the only Americans still not eligible for shots.

A leading biotechnology company, Moderna, has signed a Memorandum of Understanding (MoU) with the Kenyan government to establish a $500m mRNA vaccines and related drug manufacturing facility.. The post Biotech giant Moderna signs MoU for $500m drug factory in Kenya appeared first on The Guardian Nigeria News - Nigeria and World News .

The celebrated US scientist and inventor on not being in it for the money, why diversity improves problem-solving, and his dedication to exercising The chemical engineer Robert Langer co-founded Covid-19 vaccine maker Moderna , and his innovations have helped create more than 100 products from artificial skin to messenger RNA (mRNA) vaccines. The 73-year-old has a mountain of research papers and patents to his name, on top of which he has started more than 40 companies and won more than 200 awards, including the Queen Elizabeth prize, which has been called the “Nobel for engineering”. Langer’s biomedical engineering lab at the Massachusetts Institute of Technology, where he holds a professorship, employs more than 100 researchers. He spoke to the Observer to mark Unesco World Engineering Day for Sustainable Development , held earlier this month. Last year you debuted on Forbes magazine’s billionaires list . Being a co-founder of Moderna has been profitable! How did it feel? It’s embarrassing.

The market has probably priced in the impacts of its biggest source of revenue.

If you have the right attitude and a good strategy in hand, they might be.

It's harder for stagflation to hurt a company's bottom line when costs don't change much.

In the latest trading session, Moderna (MRNA) closed at $138.20, marking a -0.95% move from the previous day.

Moderna (MRNA) administers the first dose in the phase II study of its Omicron-specific bivalent booster candidate (mRNA-1273.214). It expects to enrol 375 subjects for the same in the United States.

A two-month interval between the first and second doses of a COVID vaccine "may be optimal" for some people, the CDC says.

Recent sell-off created a rare entry window for value investors in a secularly expensive market. See 10 beaten-down stocks that Benjamin Graham would pick.

Moderna CEO Stéphane Bancel made $18.2 million in cash, stock, and options in 2021, up from his $12.9 million compensation in 2020.

President Joe Biden's COVID-19 program faced some uncertainty Thursday, after U.S. lawmakers passed a massive new bill that would fund the federal government for the remainder of the fiscal year, as w